PharmaShots | Incisive News in 3 Shots

Subscribe Now

Reviva

Reviva Reports the Completion of Patient Enrolment in the P-III Study (RECOVER) of Brilaroxazine for Schizophrenia

Reviva Reports the Completion of Patient Enrolment in the P-III Study (RECOVER) of Brilaroxazine for Schizophrenia

August 17, 2023

Reviva Reports First Patient Dosing in P-III Study of Brilaroxazine for the Treatment of Schizophrenia

Reviva Reports First Patient Dosing in P-III Study of Brilaroxazine for the Treatment of Schizophrenia

February 1, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us